Searched for
LEDIPASVIR
Merck wins record $2.5 billion patent verdict against GileadThe judge in the case had already decided that Merck’s patent was infringed by Gilead’s Sovaldi and Harvoni, which account for more than ha...- Laurus Labs IPO subscribed 28 per cent on Day 1; 10 things you must knowThe issue received bids for 62,09,420 shares as against 2,19,11,308 on offer, data available with the stock exchanges till 5 pm showed.
- Patent not to affect hepatitis C drug price in India: Gilead Sciences Inc"It is the company's goal to enable access to these medicines for as many people as possible, as quickly as possible," the spokesperson add...
- Mylan launches generic Hepatitis C drug in IndiaDrug firm Mylan NV has launched generic Harvoni tablets, used to treat Hepatitis C, under the brand name 'MyHep LVIR' in India.
- Biocon shares gain over 5%, hit 52-week high intra-dayShares of biotechnology major Biocon today surged over 5 per cent after the company launched advanced novel therapy for the treatment of He...
- Biocon introduces advanced therapy to treat Hepatitis CBiotechnology major Biocon launches advanced novel therapy for the treatment of Hepatitis C at a fraction of the global cost.
- Cipla launches generic hepatitis C drug 'Hepcvir-L' in IndiaCipla has launched generic tablets used for treating of hepatitis C under the brand name 'Hepcvir-L' costing Rs 25,000 for a bottle of 28 t...
- Natco gets DCGI nod to launch hepatitis C drug in IndiaNatco Pharma has received approval from the Drugs Controller General of India (DCGI) to launch generic version of hepatitis C treatment dru...
- Hetero gets DCGI approval to market Hepatitis C drugHetero is the first company in India to receive the approval for the fixed-dose combination Ledipasvir-Sofosbuvir (90mg/400mg) from DCGI.
- Hepatitis C cure may cost as low as Rs 67,000India is now one of the few countries where generics are available for interferon-free treatment of Hepatitis C.
- Natco Pharma launches Hepatitis C drug in NepalNATCO priced its generic medicine, Hepcinat LP, at Rs 25,000 for a bottle of 28 tablets in Nepal, the company said in a filing to the BSE.
- Zydus Cadila launches Gilead's Hepatitis C drug in IndiaSofosbuvir is a medicine used for chronic hepatitis C infection and sold globally by Gilead Sciences Inc, under its brand Sovaldi.
- Natco Pharma ties up with Gilead on hepatitis C drugsNatco will fix its own price for the generic versions, and will pay a royalty on sales to Gilead, the company said.
- Gilead's hepatitis C drug licensing to benefit more patients: SitharamanA delegation of Gilead Sciences Inc yesterday met Commerce and Industry Minister Nirmala Sitharaman and informed about the signing of non-e...
- Hepatitis C drug in India to cost 49 lakh less than in USThe voluntary licencing deal promises to make the drug cheap in India as well as up to 91 countries where the Indian firms are allowed to s...
Load More
